Wells Fargo & Company Bio Xcel Therapeutics, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 133,676 shares of BTAI stock, worth $74,858. This represents 0.0% of its overall portfolio holdings.

Number of Shares

133,676

Previous 123,086 8.6%

Holding current value

$74,858

Previous $347,000 50.72%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.14 - $2.97 $12,072 - $31,452	10,590 Added 8.6%	133,676 $171,000
Q1 2024 May 10, 2024	BUY	$1.95 - $4.04 $88,251 - $182,838	45,257 Added 58.15%	123,086 $347,000
Q4 2023 Feb 09, 2024	BUY	$2.32 - $5.51 $6,751 - $16,034	2,910 Added 3.88%	77,829 $229,000
Q3 2023 Nov 13, 2023	SELL	$2.49 - $11.85 $6,130 - $29,174	-2,462 Reduced 3.18%	74,919 $189,000
Q2 2023 Aug 15, 2023	BUY	$6.39 - $28.58 $190,230 - $850,826	29,770 Added 62.53%	77,381 $515,000
Q1 2023 May 12, 2023	BUY	$17.7 - $33.24 $532,380 - $999,792	30,078 Added 171.55%	47,611 $888,000
Q4 2022 Feb 13, 2023	SELL	$10.25 - $22.43 $11,972 - $26,198	-1,168 Reduced 6.25%	17,533 $376,000
Q3 2022 Nov 14, 2022	BUY	$11.19 - $17.89 $20,936 - $33,472	1,871 Added 11.12%	18,701 $221,000
Q2 2022 Aug 12, 2022	BUY	$9.03 - $21.55 $27,857 - $66,481	3,085 Added 22.44%	16,830 $222,000
Q1 2022 May 16, 2022	SELL	$15.0 - $22.83 $89,385 - $136,043	-5,959 Reduced 30.24%	13,745 $288,000
Q4 2021 Feb 14, 2022	BUY	$20.12 - $35.09 $198,966 - $347,005	9,889 Added 100.75%	19,704 $400,000
Q3 2021 Nov 15, 2021	BUY	$23.84 - $32.03 $8,558 - $11,498	359 Added 3.8%	9,815 $298,000
Q2 2021 Aug 16, 2021	SELL	$29.06 - $38.83 $90,783 - $121,304	-3,124 Reduced 24.83%	9,456 $275,000
Q1 2021 May 13, 2021	SELL	$39.04 - $64.6 $717,047 - $1.19 Million	-18,367 Reduced 59.35%	12,580 $542,000
Q4 2020 Feb 09, 2021	BUY	$42.46 - $56.58 $798,587 - $1.06 Million	18,808 Added 154.94%	30,947 $1.43 Million
Q3 2020 Nov 05, 2020	SELL	$37.44 - $64.63 $119,995 - $207,139	-3,205 Reduced 20.89%	12,139 $526,000
Q2 2020 Aug 13, 2020	BUY	$17.62 - $58.71 $125,912 - $419,541	7,146 Added 87.17%	15,344 $813,000
Q1 2020 May 14, 2020	BUY	$12.26 - $41.14 $100,507 - $337,265	8,198 New	8,198 $184,000

Others Institutions Holding BTAI

# of Institutions

Shares Held

7.26M

Call Options Held

101K

Put Options Held

205K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $15.7M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Bio Xcel Therapeutics, Inc. Transaction History